NCT07154290 2026-02-12A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Regeneron PharmaceuticalsPhase 2 Not yet recruiting300 enrolled